Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.81 +0.05 (+2.84%)
As of: Oct 22, 2026 · 3:23 PM EDT

Processa Pharmaceuticals (PCSA) Short-term Investments (2018)

Updated

Processa Pharmaceuticals (PCSA) recorded Short-term Investments of $496,201 in Q2 2018.

Analysis

Processa Pharmaceuticals (PCSA) Short-term Investments (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.42 Bn 1,139.01 Bn 19.71 Bn
2 Johnson & Johnson 648.22 Bn 568.08 Bn 17.30 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn
4 Merck 369.14 Bn 323.52 Bn 12.21 Bn
5 Novartis Ag 303.29 Bn 267.28 Bn 11.24 Bn
6 Astrazeneca 268.21 Bn 241.90 Bn 12.86 Bn
7 Amgen 242.56 Bn 197.96 Bn 7.24 Bn
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn
9 Pfizer 173.28 Bn 119.92 Bn 10.94 Bn
10 Processa Pharmaceuticals 4.98 Mn -8.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 496,201.00
API Access

Processa Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=PCSA&period=max&api_key=YOUR_API_KEY